Atlas Trials

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Clinical trial NCT01275599 · COMPLETED

Trial details

NCT number
NCT01275599
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis COpioid-Related Disorders
Start date
2011-01-01
Primary completion
2011-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.